Skip to main content

Animations

MJFF Publications

4901 - 4910 of 6465 Results
Title
Year
  • Year
  • 2020
  • 2017
  • 2024
  • 2024
  • 2020
  • 2017
  • 2022
  • 2023
  • 2014
  • 2024
  • Summary Details
    OPEN
    Title: Multimodal assessment of nigrosomal degeneration in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.021
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Mild cognitive impairment as a risk factor for Parkinson's disease dementia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27002
    Citation Count: 159
  • Summary Details
    OPEN
    Title: CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jcim.4c01267
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
    Journal Name: Receptors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/receptors3020009
    Citation Count: 43
  • Summary Details
    OPEN
    Title: A novel method for calculating beta band burst durations in Parkinson’s disease using a physiological baseline
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2020.108811
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.03.017
    Citation Count: 80
  • Summary Details
    OPEN
    Title: S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.1508-21.2022
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.scr.2023.103085
    Citation Count: 3
  • Summary Details
    OPEN
    Title: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007
    Citation Count: 45
  • Summary Details
    OPEN
    Title: New insights from a Malaysian real-world deep brain stimulation cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241297715
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.